News
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a ...
The company’s underlying business is thriving, with analysts projecting its market value could hit $1 trillion in the coming ...
Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...
Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the Danish ...
AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a ...
Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks to acquire gene editing biotech Verve Therapeutics Inc.
Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, aiming to ...
A third-party health insurance payer can proceed as a class in a racketeering lawsuit against Takeda Pharmaceuticals Co. and Eli Lilly & Co., a federal appeals panel ruled Monday.
Eli Lilly employees join forces for community service with Connecting Hearts at Home initiative in central Indiana, ...
U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...
The stock's fall snapped a six-day winning streak.
Reuters on MSN14h
Lilly will offer higher doses of Zepbound on its websiteEli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results